本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fate Therapeutics Inc

2.00
-0.1300-6.10%
盘后:2.000.00000.00%19:30 EDT
成交量:95.35万
成交额:194.07万
市值:2.40亿
市盈率:-1.90
高:2.13
开:2.13
低:1.98
收:2.13
52周最高:3.23
52周最低:0.9500
股本:1.20亿
流通股本:1.05亿
量比:0.98
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-1.0528
每股收益(LYR):-1.1500
净资产收益率:-60.75%
总资产收益率:-26.22%
市净率:1.56
市盈率(LYR):-1.74

数据加载中...

2021/06/16

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/07

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/25

重要事件披露

8-K - Current report
2021/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/24

重要事件披露

8-K - Current report
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/08

重要事件披露

8-K - Current report
2021/01/05

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/12/22

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report